Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia
Authors:
- Qiu-Qin XuQXQiu-Qin Xu
- Qi ZhangQZQi Zhang
- Wei-Ping ZhangWZWei-Ping Zhang
- Li-Hui ZhangLZLi-Hui Zhang
- Er-Qing WeiEWEr-Qing Wei
- 1 October 2005
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 387 (1) , 5-10
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Ultrastructural changes in tracheobronchial epithelia following experimental traumatic brain injury in rats: Protective effect of erythropoietinThe Journal of Heart and Lung Transplantation, 2004
- A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemiaTransfusion and Apheresis Science, 2004
- Intranasal administration of interferon beta bypasses the blood–brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosisJournal of Neuroimmunology, 2004
- Erythropoietin as a Tissue-Protective Cytokine in Brain Injury: What Do We Know and Where Do We Go?The Neuroscientist, 2004
- Sniffing neuropeptides: a transnasal approach to the human brainNature Neuroscience, 2002
- Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusionNeuroscience Letters, 2001
- Increased Cerebral Infarct Volumes in Polyglobulic Mice Overexpressing ErythropoietinJournal of Cerebral Blood Flow & Metabolism, 2001
- A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in MiceJournal of Cerebral Blood Flow & Metabolism, 1999
- Quantitative analysis of the olfactory pathway for drug delivery to the brainBrain Research, 1995
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989